Dongrui Deng

2.3k total citations · 1 hit paper
63 papers, 1.4k citations indexed

About

Dongrui Deng is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Dongrui Deng has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Obstetrics and Gynecology, 20 papers in Pediatrics, Perinatology and Child Health and 18 papers in Immunology. Recurrent topics in Dongrui Deng's work include Pregnancy and preeclampsia studies (16 papers), Cervical Cancer and HPV Research (11 papers) and Reproductive System and Pregnancy (8 papers). Dongrui Deng is often cited by papers focused on Pregnancy and preeclampsia studies (16 papers), Cervical Cancer and HPV Research (11 papers) and Reproductive System and Pregnancy (8 papers). Dongrui Deng collaborates with scholars based in China, Germany and United Kingdom. Dongrui Deng's co-authors include Ling Feng, Haiyi Liu, Shaoshuai Wang, Xingguang Lin, Wanjiang Zeng, Juan Xiao, Jianli Wu, Wei Li, Nan Yu and Qingling Kang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dongrui Deng

60 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

2020 577 citations Nan Yu, Wei Li et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Dongrui Deng

Since Specialization

Citations

This map shows the geographic impact of Dongrui Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongrui Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongrui Deng more than expected).

Fields of papers citing papers by Dongrui Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongrui Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongrui Deng. The network helps show where Dongrui Deng may publish in the future.

Co-authorship network of co-authors of Dongrui Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Dongrui Deng. A scholar is included among the top collaborators of Dongrui Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongrui Deng. Dongrui Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VCPIP1 potentiates innate immune responses by non-catalytically reducing the ubiquitination of IRAK1/2 2025 ·Cell Reports ·(unknown), (unknown), Jianzhao Zhang, (unknown), Dongrui Deng, (unknown), (unknown), (unknown), Baoli Cheng, Jinghua Liu, Xu Wang	0
2	Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation 2025 ·Cancer Cell International ·Qinrong Wang, (unknown), Lingling Liu, Dongrui Deng, (unknown), (unknown), Yuan Xie, Yinhui Jiang, (unknown), Jian Zhang, Ying Liu	0
3	Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study 2023 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), Xinwei Shi, (unknown), (unknown), Peng Xu, Dongrui Deng, (unknown), Suhua Chen, (unknown), Ling Feng, Yuanyuan Wu	3
4	Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation 2023 ·Open Life Sciences ·(unknown), (unknown), Xinwei Shi, Wanjiang Zeng, Dongrui Deng, Suhua Chen, Fuyuan Qiao, Ling Feng, Yuanyuan Wu	0
5	Developing and Validating Nomogram to Predict Severe Postpartum Hemorrhage in Women With Placenta Previa Undergoing Cesarean Delivery: A Multicenter Retrospective Case-Control Study 2022 ·Frontiers in Medicine ·(unknown), Li Zhang, (unknown), Jie Xu, Hui Du, Shaoshuai Wang, (unknown), Dongrui Deng, Suhua Chen, Wanjiang Zeng, Ling Feng, Haiyi Liu	5
6	Immunopathogenesis of patients with COVID-19: from the perspective of immune system ‘evolution’ and ‘revolution’ 2022 ·Expert Reviews in Molecular Medicine ·(unknown), (unknown), Xingguang Lin, R. Wang, Di Wu, Rui Long, Mengzhou He, Shujie Liao, Dongrui Deng	3
7	Integrated analysis of multiple microarray studies to identify potential pathogenic gene modules in preeclampsia 2021 ·Experimental and Molecular Pathology ·(unknown), Yin Xie, Yanan Sun, (unknown), (unknown), Xuanxuan Li, (unknown), Mengzhou He, Yao Fan, Dongrui Deng	5
8	Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study breakdown → 2020 ·The Lancet Infectious Diseases ·Nan Yu, Wei Li, Qingling Kang, Zhi Xiong, Shaoshuai Wang, Xingguang Lin, Yanyan Liu, Juan Xiao, Haiyi Liu, Dongrui Deng, Suhua Chen, Wanjiang Zeng, Ling Feng, Jianli Wu	577
9	Alteration of heat shock protein 20 expression in preeclamptic patients and its effect in vascular and coagulation function 2018 ·Frontiers of Medicine ·Fanfan Li, Mengzhou He, (unknown), Yao Fan, Yun Chen, Xi Xia, Yin Xie, Dongrui Deng	3
10	Multifaceted spiral suture 2017 ·Medicine ·Yifan Meng, Peng Wu, Dongrui Deng, (unknown), Xingguang Lin, (unknown), (unknown), (unknown), Ling Feng, Haiyi Liu, (unknown)	9
11	A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta previa–accreta 2017 ·Medicine ·Yao Fan, Xun Gong, Nan Wang, Ketao Mu, Ling Feng, (unknown), Suhua Chen, (unknown), Haiyi Liu, Yuanyuan Wu, Qiong Zhou, (unknown), (unknown), (unknown), Fanfan Li, Mengzhou He, (unknown), Dongrui Deng	32
12	Involvement of dysregulated IKCa and SKCa channels in preeclampsia 2017 ·Placenta ·Fanfan Li, Mengzhou He, Yin Xie, Yuanyuan Wu, (unknown), Yao Fan, Fuyuan Qiao, Dongrui Deng	20
13	New medical risks affecting obstetrics after implementation of the two-child policy in China 2017 ·Frontiers of Medicine ·Qiang Li, Dongrui Deng	21
14	Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia 2017 ·BMC Pregnancy and Childbirth ·Ying Zhang, Hao Liu, Xinwei Shi, Fuyuan Qiao, (unknown), Ling Feng, Dongrui Deng, Haiyi Liu, Yuanyuan Wu	26
15	A novel “priming-boosting” strategy for immune interventions in cervical cancer 2015 ·Molecular Immunology ·Shujie Liao, Weina Zhang, (unknown), Wei Wang, Dongrui Deng, Hui Wang, Changyu Wang, Jianfeng Zhou, Shixuan Wang, Hanwang Zhang, Ding Ma	11
16	Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis 2015 ·BMC Medical Genetics ·Shaoshuai Wang, Haiying Sun, Jia Yao, Fangxu Tang, Hang Zhou, Xiong Li, Jin Zhou, Kecheng Huang, Qinghua Zhang, Ting Hu, Ru Yang, Changyu Wang, Ling Xi, Dongrui Deng, Hui Wang, Shixuan Wang, Ding Ma, Shuang Li	13
17	Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo 2012 ·Oncology Reports ·Shujie Liao, Dongrui Deng, Weina Zhang, (unknown), Wei Wang, Hui Wang, Yunping Lu, Shixuan Wang, Meng Li, Ding Ma	30
18	HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7 2012 ·International Journal of Molecular Medicine ·Shujie Liao, Dongrui Deng, (unknown), Wei Wang, Li Li, Wei Li, Jianfeng Zhou, Gang Xu, Meng Li, Shixuan Wang, Ding Ma	12
19	Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation 2012 ·Journal of Huazhong University of Science and Technology [Medical Sciences] ·Xiangyi Ma, Danfeng Luo, Kezhen Li, Ronghua Liu, Yan Liu, Tao Zhu, Dongrui Deng, Jianfeng Zhou, Meng Li, Shixuan Wang, Ding Ma	9
20	The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro 2011 ·International Journal of Gynecological Cancer ·Dongrui Deng, Shujie Liao, Xiangyang Bai, Wei Wang, Ni Sima, Qian Xu, (unknown), Gang Xu, Jianfeng Zhou, Shixuan Wang, Meng Li, Ding Ma	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact